Searching US Patent Collection...

	PAT. NO.		Title
1	10,987,313		Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
2	10,973,769		Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
3	10,905,652		Compositions for treatment of attention deficit hyperactivity disorder
4	10,881,618		Compositions for treatment of attention deficit hyperactivity disorder
5	10,688,179		Treatment of autism spectrum disorder and associated symptoms
6	10,688,058		Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
7	10,617,651		Compositions for treatment of attention deficit hyperactivity disorder
8	10,369,078		Dual-chamber pack for pharmaceutical compositions
9	10,292,937		Methods of treatment of attention deficit hyperactivity disorder
10	10,292,935		Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
11	10,285,908		Dual-chamber pack
12	10,258,583		Extended release liquid compositions of guanfacine
13	10,238,803		Drug delivery device for pharmaceutical compositions
14	10,182,995		Compositions for treatment of attention deficit hyperactivity disorder
15	10,179,108		Compositions for treatment of attention deficit hyperactivity disorder
16	10,098,848		Inositol-containing comestible units and methods of treatment using the same
17	10,098,845		Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
18	9,962,345		Oral liquid compositions of guanfacine
19	9,962,336		Extended release suspension compositions
20	9,901,640		Controlled release formulations of levodopa and uses thereof
21	9,889,095		Methods for treatment of attention deficit hyperactivity disorder
22	9,603,812		Treatment of autistic spectrum disorder
23	9,603,809		Methods of treatment of attention deficit hyperactivity disorder
24	9,603,808		Method of treatment of attention deficit hyperactivity disorder
25	9,585,842		Sustained release guanfacine HCL formulation
26	9,533,046		Controlled release formulations of levodopa and uses thereof
27	9,511,032		Compositions for treatment of attention deficit hyperactivity disorder
28	9,498,447		Compositions for treatment of attention deficit hyperactivity disorder
29	9,463,246		Controlled release formulations of levodopa and uses thereof
30	9,289,394		Compositions for treatment of attention deficit hyperactivity disorder
31	9,283,214		Compositions for treatment of attention deficit hyperactivity disorder
32	9,211,284		Diagnosis and treatment of P.R.I.C.E. syndrome
33	9,119,809		Compositions for treatment of attention deficit hyperactivity disorder
34	9,034,902		Methods for treatment of attention deficit hyperactivity disorder
35	9,028,868		Methods and compositions for treatment of attention deficit disorder
36	9,023,389		Compositions for treatment of attention deficit hyperactivity disorder
37	9,011,912		Extended-release oral dosage forms for poorly soluble amine drugs
38	8,927,010		Compositions for treatment of attention deficit hyperactivity disorder
39	8,916,588		Methods for treatment of attention deficit hyperactivity disorder
40	7,884,122		Extended release formulation and method of treating adrenergic dysregulation
41	7,820,645		Crystalline forms
42	7,803,954		Mandelic acid derivatives and their use as thrombin inhibitors
43	7,781,424		Modified release pharmaceutical formulation
44	7,763,597		Salts
45	7,700,582		Pharmaceutical formulation
46	7,645,751		Mandelic acid derivatives and their use as thrombin inhibitors
47	7,364,755		Modified calcium phosphate excipient